Yoshida Pediatric Clinic; Osaka, Japan.
Hum Vaccin Immunother. 2013 May;9(5):989-92. doi: 10.4161/hv.23427. Epub 2013 Jan 16.
A 69-y-old man with a history of hepatitis C since May 1985 and his 6 healthy immediate relatives were examined for hemagglutination inhibition antibodies against 2009 pandemic influenza A/H1N1 virus. This patient had a hemagglutination inhibition antibody titer of 640 against 2009 pandemic influenza A/H1N1 virus in a serum sample collected on July 4, 1999, and the antibody titers fluctuated between 40 and 320 in serum samples collected after 1999. The fluctuations in hemagglutination inhibition antibody titers against pandemic 2009 influenza A/H1N1 virus were not consistent with his history of seasonal influenza, and our results suggest a relationship to his vaccination with seasonal trivalent inactivated influenza vaccine. This patient as well as three relatives showed cross-reactive antibody titers of 10 or more against 2009 pandemic A/H1N1 influenza virus in serum samples taken after June 1999. From these results we conclude that the cross-reactivity to pandemic 2009 A/H1N1 influenza virus emerged after June 1999.
一位 69 岁的男性,自 1985 年 5 月起患有丙型肝炎,他的 6 位健康直系亲属接受了针对 2009 年甲型 H1N1 流感大流行病毒的血凝抑制抗体检测。该患者于 1999 年 7 月 4 日采集的血清样本中对 2009 年甲型 H1N1 流感大流行病毒的血凝抑制抗体滴度为 640,并且 1999 年之后采集的血清样本中抗体滴度在 40 到 320 之间波动。针对大流行的 2009 年甲型 H1N1 流感病毒的血凝抑制抗体滴度的波动与他的季节性流感史不一致,我们的结果表明这与他接种季节性三价灭活流感疫苗有关。该患者以及其他 3 位亲属在 1999 年 6 月之后采集的血清样本中针对 2009 年甲型 H1N1 流感大流行病毒的交叉反应抗体滴度均为 10 或更高。根据这些结果,我们得出结论,针对 2009 年甲型 H1N1 流感大流行病毒的交叉反应性出现在 1999 年 6 月之后。